Effect of Attention Deficit Hyperactivity Disorder Knowledge Improvement Program on Male Primary School Teachers

December 11, 2019 updated by: Abdullah Mohammed Alshehri, King Khalid University

Effect of Attention Deficit Hyperactivity Disorder Knowledge Improvement Program on Male Primary School Teachers in Abha City: A Randomized Controlled Trial

The study aims to assess the impact of implementing ADHD knowledge improvement program on male primary school teachers' knowledge regarding ADHD in Abha City, Saudi Arabia.

Study Overview

Detailed Description

Primary school teachers play an essential role in early detection and proper treatment of school children suffering attention deficit hyperactivity disorder (ADHD). There are indications that teachers may not have enough knowledge about this disorder. Training programs can help to improve the knowledge of teachers about ADHD.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male teachers in governmental and private primary schools in Abha City, Saudi Arabia.

Exclusion Criteria:

  • Those who have a similar training program before.
  • Those who are not directly involved in the teaching process.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training
group will receive training about ADHD
This training program will cover an overview of ADHD, prevalence, causes, symptoms, risk factors, associated impairment, prognosis, and treatment options including behavioral interventions and medication.
No Intervention: Control
group will not receive training about ADHD

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Teachers' Knowledge questionnaire
Time Frame: 1 month
A self-administered questionnaire. The questionnaire composed of 6 items covering socio-demographic characteristics of teachers (age, nationality, years of experience, education level, specialty and type of school) and 20 items assessing teachers' knowledge of ADHD. Each item was assessed on a 2-point scale (incorrect response and don't know = 0, correct response = 1) with a maximum score of 20. The questionnaire items were as follows: nature of disease (1 item), age of onset (1 item), sex prevalence (1 item), disease course (1 item), symptoms (7 items), risk factors (4 items), aggravating factors (4 items) and management (1 item). Adequate knowledge was considered when the teachers achieved 65% of the total score.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2019

Primary Completion (Anticipated)

January 1, 2020

Study Completion (Anticipated)

February 1, 2020

Study Registration Dates

First Submitted

December 8, 2019

First Submitted That Met QC Criteria

December 10, 2019

First Posted (Actual)

December 12, 2019

Study Record Updates

Last Update Posted (Actual)

December 13, 2019

Last Update Submitted That Met QC Criteria

December 11, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ADHD

Clinical Trials on Knowledge Improvement Program about ADHD

3
Subscribe